HORNBILL: A First-in-Human Phase I/IIa Study of the Safety, Tolerability, and Early Pharmacodynamics of BI 764524 for Diabetic Macular Ischemia
2025 · Ophthalmology Science · 3 citations
https://doi.org/10.1016/j.xops.2025.100781
M
Mohamed Ahmed
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
1.5K
Citations
13
h-index
14
i10-index
Mohamed Ahmed is an academic researcher from University of Arizona. The author has contributed to research in topics: Pulmonary Hypertension Research and Treatments & Eicosanoids and Hypertension Pharmacology & Neonatal Respiratory Health Research. The author has an h-index of 13, co-authored 31 publications.
Papers by this author
worksTailored CD4+ lymphocytes expressing human CHAT protein as a novel vasodilator in attenuating RV pressure in PAH animal model
2025 · Translational research · 0 citations
https://doi.org/10.1016/j.trsl.2025.02.001
eNAMPT/TLR4 signaling drives PAH cellular phenotypic switching and lung vascular remodeling
2025 · Cell Communication and Signaling · 0 citations
https://doi.org/10.1186/s12964-025-02421-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat